ZLAB's logo.
Ticker Symbol: ZLAB

Zai Lab Limited - ADR

$91.01 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: China (Mainland) Currency: USD Asset Type: ADR CIK:0001704292

Company Profile

Zai Lab ) is an innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China's pharmaceutical market and address unmet medical needs, Zai Lab's experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates. Zai Lab has also built an in-house team with strong drug discovery and translational research capabilities, aiming to establish a global pipeline of proprietary drug candidates against targets in itsfocus areas. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Pudong
CEO: N/A
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $23.43
Change: -$0.40 ( -1.68%)
Days Range: $23.01 - $23.65
Beta: 1.33
52wk. High: $49.81
52wk. Low: $20.98
Ytd. Change -24.06%
50 Day Moving Average: $24.98
200 Day Moving Average: $28.98
Shares Outstanding: 98838743

Valuation

Market Cap: 231.6B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A